Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 201

1.

Equine herpesvirus type 1 modified live virus vaccines: quo vaditis?

Rosas CT, Goodman LB, von Einem J, Osterrieder N.

Expert Rev Vaccines. 2006 Feb;5(1):119-31. Review.

PMID:
16451114
2.

Comparison of the efficacy of inactivated combination and modified-live virus vaccines against challenge infection with neuropathogenic equine herpesvirus type 1 (EHV-1).

Goodman LB, Wagner B, Flaminio MJ, Sussman KH, Metzger SM, Holland R, Osterrieder N.

Vaccine. 2006 Apr 24;24(17):3636-45. Epub 2006 Feb 13.

PMID:
16513225
3.

A vectored equine herpesvirus type 1 (EHV-1) vaccine elicits protective immune responses against EHV-1 and H3N8 equine influenza virus.

Van de Walle GR, May MA, Peters ST, Metzger SM, Rosas CT, Osterrieder N.

Vaccine. 2010 Jan 22;28(4):1048-55. doi: 10.1016/j.vaccine.2009.10.123. Epub 2009 Nov 6.

PMID:
19897066
5.

The equine immune response to equine herpesvirus-1: the virus and its vaccines.

Kydd JH, Townsend HG, Hannant D.

Vet Immunol Immunopathol. 2006 May 15;111(1-2):15-30. Epub 2006 Feb 14. Review.

PMID:
16476492
6.

Serological responses and clinical outcome after vaccination of mares and foals with equine herpesvirus type 1 and 4 (EHV-1 and EHV-4) vaccines.

Bresgen C, Lämmer M, Wagner B, Osterrieder N, Damiani AM.

Vet Microbiol. 2012 Nov 9;160(1-2):9-16. doi: 10.1016/j.vetmic.2012.04.042. Epub 2012 May 8.

PMID:
22633483
7.

Antibody and cellular immune responses following DNA vaccination and EHV-1 infection of ponies.

Soboll G, Hussey SB, Whalley JM, Allen GP, Koen MT, Santucci N, Fraser DG, Macklin MD, Swain WF, Lunn DP.

Vet Immunol Immunopathol. 2006 May 15;111(1-2):81-95. Epub 2006 Mar 23.

PMID:
16549215
8.

Immune responses to commercial equine vaccines against equine herpesvirus-1, equine influenza virus, eastern equine encephalomyelitis, and tetanus.

Holmes MA, Townsend HG, Kohler AK, Hussey S, Breathnach C, Barnett C, Holland R, Lunn DP.

Vet Immunol Immunopathol. 2006 May 15;111(1-2):67-80. Epub 2006 Feb 14.

PMID:
16476488
9.

Equid herpesvirus (EHV-1) live vaccine strain C147: efficacy against respiratory diseases following EHV types 1 and 4 challenges.

Patel JR, Földi J, Bateman H, Williams J, Didlick S, Stark R.

Vet Microbiol. 2003 Mar 20;92(1-2):1-17.

PMID:
12488066
10.

Intramuscular Immunization of Mice with the Live-Attenuated Herpes Simplex Virus 1 Vaccine Strain VC2 Expressing Equine Herpesvirus 1 (EHV-1) Glycoprotein D Generates Anti-EHV-1 Immune Responses in Mice.

Liu SA, Stanfield BA, Chouljenko VN, Naidu S, Langohr I, Del Piero F, Ferracone J, Roy AA, Kousoulas KG.

J Virol. 2017 May 26;91(12). pii: e02445-16. doi: 10.1128/JVI.02445-16. Print 2017 Jun 15.

11.

Characterisation of CTL and IFN-gamma synthesis in ponies following vaccination with a NYVAC-based construct coding for EHV-1 immediate early gene, followed by challenge infection.

Paillot R, Ellis SA, Daly JM, Audonnet JC, Minke JM, Davis-Poynter N, Hannant D, Kydd JH.

Vaccine. 2006 Mar 6;24(10):1490-500. Epub 2005 Oct 21.

PMID:
16269205
12.
14.

Use of DNA and recombinant canarypox viral (ALVAC) vectors for equine herpes virus vaccination.

Minke JM, Fischer L, Baudu P, Guigal PM, Sindle T, Mumford JA, Audonnet JC.

Vet Immunol Immunopathol. 2006 May 15;111(1-2):47-57. Epub 2006 Mar 31.

PMID:
16580075
15.
16.

Vaccination of ponies with the IE gene of EHV-1 in a recombinant modified live vaccinia vector protects against clinical and virological disease.

Soboll G, Breathnach CC, Kydd JH, Hussey SB, Mealey RM, Lunn DP.

Vet Immunol Immunopathol. 2010 May 15;135(1-2):108-17. doi: 10.1016/j.vetimm.2009.11.009. Epub 2009 Nov 24.

PMID:
20018383
17.

Serum antibody responses to equine herpesvirus 1 glycoprotein D in horses, pregnant mares and young foals.

Foote CE, Love DN, Gilkerson JR, Rota J, Trevor-Jones P, Ruitenberg KM, Wellington JE, Whalley JM.

Vet Immunol Immunopathol. 2005 May 1;105(1-2):47-57.

PMID:
15797474
18.

The mucosal humoral immune response of the horse to infective challenge and vaccination with equine herpesvirus-1 antigens.

Breathnach CC, Yeargan MR, Sheoran AS, Allen GP.

Equine Vet J. 2001 Nov;33(7):651-7.

PMID:
11770985
19.
20.

[Mutations in the US2 and glycoprotein B genes of the equine herpesvirus 1 vaccine strain RacH have no effects on its attenuation].

Neubauer A, Meindl A, Osterrieder N.

Berl Munch Tierarztl Wochenschr. 1999 Sep;112(9):351-4. German.

PMID:
10507185

Supplemental Content

Support Center